Angeles, Arlou Kristina http://orcid.org/0000-0002-1917-2932
Christopoulos, Petros
Yuan, Zhao
Bauer, Simone
Janke, Florian http://orcid.org/0000-0002-2406-7037
Ogrodnik, Simon John
Reck, Martin
Schlesner, Matthias http://orcid.org/0000-0002-5896-4086
Meister, Michael
Schneider, Marc A.
Dietz, Steffen
Stenzinger, Albrecht
Thomas, Michael
Sültmann, Holger http://orcid.org/0000-0002-5257-8600
Funding for this research was provided by:
Deutsche Zentrum für Lungenforschung
German Cancer Consortium (DKTK); Heidelberg Center for Personalized Oncology at the German Cancer Research Center (DKFZ-HIPO); Roche Sequencing Solutions
Article History
Received: 2 June 2021
Accepted: 22 October 2021
First Online: 7 December 2021
Competing interests
: P.C. reports research funding from AstraZeneca, Novartis, Roche, and Takeda as well as advisory board and/or lecture fees from Boehringer Ingelheim, Chugai, Lilly, Pfizer, and Takeda, outside the submitted work. M.A.S. reports personal fees from the German Canter for Lung Research (DZL), outside the submitted work. S.D. reports speaker’s honoraria from Roche and research funding from Takeda, outside the submitted work. M.R. reports personal fees from Amgen, AstraZeneca, BMS, Boehringer Ingelheim, Lilly, Merck, MSD, Novartis, Pfizer, Roche, and Samsung, outside the submitted work. M.T. reports advisory board honoraria from Novartis, Lilly, BMS, MSD, Roche, Celgene, Takeda, AbbVie, Boehringer, speaker’s honoraria from Lilly, MSD, Takeda, research funding from AstraZeneca, BMS, Celgene, Novartis, Roche and travel grants from BMS, MSD, Novartis, Boehringer, outside the submitted work. A.S. reports advisory board honoraria from BMS, Bayer, AstraZeneca, Thermo Fisher, Novartis, Seattle Genomics speaker’s honoraria from BMS, Bayer, Illumina, AstraZeneca, Novartis, Thermo Fisher, MSD, Roche, as well as research funding from Chugai, Bayer and BMS, outside the submitted work. H.S. reports grants from Roche Sequencing Solutions, during the conduct of the study, and personal fees from Roche, outside the submitted work. The remaining authors declare no competing interests.